Salmon DNA Combination for Hypertrohic Scar Treatment with Diabetes Mellitus Type 2: A Case Report

Main Article Content

Andi Muh. Octavian Pratama
Arif Rahmat Muharram

Abstract

Background: Hypertrophic scar is a problem of wound healing process. Salmon DNA (Polydeoxyribonucleotide/PDRN) is a mixture of deoxyribonucleotide gonads derivate of Oncorhynchus mykiss (Rainbow Salmon) that helps wound healing process and preventing the formation of scars.


Methods: A diabetic 30-year-old man with 5x3 cm hypertrophic scar on his dorsal hand since 10 months. The hypertrophic scar had been treated with ointments and Triamcinolone 10mg/ml every 2 weeks for 2 months. The patient was treated with intradermal injection 2% Polydeoxyribonucleotide (PDRN) in 2.7 ml (PDRN Bellavita®) and topical therapy containing Allium cepa extract and Vitamin E (Lanakeloid®) every 12 hours. PDRN was injected intradermal into the whole area of the scar using a 30-G Needle at a dose of 0.05 ml at each injection site with a distance of about 0.5-1.0 cm. PDRN was given every 2 weeks for 3 months. Vancouver Scar Scale was used to asses hypertrophic scar treatment progress.


Results: The Vancouver Scar Scale was downgrading from 10 to 3 in 3 months.


Conclusion: The combination of PDRN injection with topical administration of Allium cepa and vitamin E, is effective for hypertrophic scar treatment.

Article Details

How to Cite
Pratama, A. M. O., & Muharram , A. R. . (2022). Salmon DNA Combination for Hypertrohic Scar Treatment with Diabetes Mellitus Type 2: A Case Report. International Journal of Medical Science and Clinical Research Studies, 2(08), 846–849. https://doi.org/10.47191/ijmscrs/v2-i8-23
Section
Articles

References

I. Wang ZC, Zhao WY, Cao Y, et al. The Roles of Inflammation in Keloid and Hypertrophic Scars. Front Immunol. 2020; 11:603187. Published 2020 Dec 4. doi:10.3389/fimmu.2020.603187

II. Galeano M, Pallio G, Irrera N, et al. Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing. Pharmaceuticals (Basel). 2021; 14(11):1103.

Published 2021 Oct 29. Doi: 10.3390/ph14111103

III. Jeong W, Yang CE, Roh TS, Kim JH, Lee JH, Lee WJ. Scar prevention and enhanced wound healing induced by polydeoxyribonucleotide in a rat incisional wound-healing model. Int J Mol Sci. 2017; 18(8):1698. https://doi.org/10.3390/ijms18081698 PMid:28771195

IV. Huang, C.; Ogawa, R. Role of Inflammasomes in Keloids and Hypertrophic Scars—Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis. Int. J. Mol. Sci. 2022, 23, 6820.

https://doi.org/10.3390/ijms23126820

V. Belmontesi M. Polydeoxyribonucleotide for the improvement of a hypertrophic retracting scar-An interesting case report. Journal of Cosmetic Dermatology (2020)

VI. Kramiča K, Mihailova D, Hartmane I. Hypertrophic Scar Treatment by Polydeoxyribonucleotide Intralesional Injections in Combination with Corticosteroid, Laser and Silicone Effects. Abstract from RSU Research week 2021: Knowledge for Use in Practice, Rīga, Latvia (2021)

VII. Noh TK, et al. Novel Anti-Melanogenesis Properties Of Polydeoxyribonucleotide, A Popular Wound Healing Booster. Int J Mol Sci. 2016; 17(9):1448.

VIII. Conti V, et al. Effectiveness and Tolerability of a Patch Containing Onion Extract and Allantoin for Cesarean Section Scars. Front. Pharmacol (2020)

Most read articles by the same author(s)